PRODUCTS
SERVICES
COMPANY
CONTACT
FAQ
Search
Dictionary
Mobile
Login
Login/Nickname:
Password:
Remember login
Login
Send password reminder...
Morito Monden Selected Research
Drug Therapy (Chemotherapy)
05/2008
The activation of Akt during preoperative chemotherapy for esophageal cancer correlates with poor prognosis.
12/2007
New chemotherapy for patients with advanced hepatocellular carcinoma: Pilot study of beta-interferon and doxorubicin one-shot intra-arterial chemotherapy.
11/2007
[A case of hepatocellular carcinoma with right atrium tumor thrombus treated with combined doxorubicin and interferon-beta/intra-arterial injection chemotherapy and hepatectomy]
11/2007
[Neoadjuvant chemotherapy for gastric cancer with peritoneal dissemination]
05/2007
The effect of neoadjuvant chemotherapy on lymph node micrometastases in squamous cell carcinomas of the thoracic esophagus.
04/2007
Successful treatment of multiple hepatocellular carcinoma with tumor thrombi in the major portal branches by intraarterial 5-fluorouracil perfusion chemotherapy combined with subcutaneous interferon-alpha and hepatectomy.
11/2006
[Intra arterial infusion chemotherapy combined with interferon-alpha following palliative hepatic resection against advanced hepatoma with portal venous tumor thrombus in the major trunk and multiple nodules--a preliminary study]
09/2006
[The progress of hepatic arterial infusion chemotherapy for hepatocellular carcinoma]
02/2006
Clinical significance of class III beta-tubulin expression and its predictive value for resistance to docetaxel-based chemotherapy in gastric cancer.
10/2005
[Successful treatment of combined intraarterial (5-fluorouracil and adriamycin and cisplatin) infusion chemotherapy for advanced hepatocellular carcinoma with multiple intrahepatic metastases and/or portal vein thrombosis--two case reports]
12/2004
Can metallothionein be a useful molecular marker for selecting hepatocellular carcinoma patients for platinum-based chemotherapy?
12/2004
[Hepatic arterial infusion chemotherapy (HAIC)--hepatocellular carcinoma]
10/2004
Preoperative intraperitoneal chemotherapy for patients with serosa-infiltrating gastric cancer.
10/2004
[Two cases of advanced and recurrent gastric cancer treated with the combination of chemotherapy and radiation]
10/2004
[Cases of postoperative hepatic metastasis from gastric cancer in which hepatic arterial infusion chemotherapy with 5-FU, adriamycin and cisplatin was performed after TS-1 chemotherapy]
10/2004
[Successful treatment for advanced cholangiocellular carcinoma with intrahepatic metastasis and/or portal vein tumor thrombi by intraarterial chemotherapy combined with 5-fluorouracil, adriamycin and cisplatin (FAP)--two cases report]
08/2004
[Recent progress in chemotherapy for hepatocellular carcinoma]
04/2004
[Weekly administration of paclitaxel as a second-line chemotherapy for advanced and recurrent gastric cancer]
11/2003
[The chemotherapy for hepatocellular carcinoma]
10/2003
[A report of two cases--two patients of the extremely advanced hepatocellular carcinoma have responded completely for a long time after a combination therapy consisting of arterial chemotherapy and injection of interferon-alpha]
10/2003
[Two advanced gastric cancer patients who showed malignant ileus soon after administration of combination therapy of preoperative intra-peritoneal chemotherapy and gastrectomy]
10/2003
Reduced MLH1 expression after chemotherapy is an indicator for poor prognosis in esophageal cancers.
11/2002
[A case of postoperative multiple hepatic metastasis from gastric cancer successfully treated by percutaneous microwave coagulation therapy and hepatic arterial infusion chemotherapy]
09/2002
Neoadjuvant chemotherapy followed by salvage surgery: effect on survival of patients with primary noncurative gastric cancer.
Articles by Research Topic
Disease
49
Hepatocellular Carcinoma (Hepatoma)
04/2008 - 01/2002
29
Neoplasms (Cancer)
03/2008 - 01/2002
18
Neoplasm Metastasis (Metastasis)
04/2008 - 06/2002
18
Stomach Neoplasms (Stomach Cancer)
11/2007 - 05/2002
12
Carcinoma (Carcinomatosis)
03/2008 - 04/2002
9
Thrombosis (Thrombus)
12/2007 - 02/2005
8
Esophageal Neoplasms (Esophageal Cancer)
05/2008 - 07/2002
8
Colorectal Neoplasms (Colorectal Cancer)
02/2008 - 06/2002
8
Pancreatic Neoplasms (Pancreatic Cancer)
01/2008 - 08/2003
4
Colonic Neoplasms (Colon Cancer)
02/2006 - 05/2005
4
Breast Neoplasms (Breast Cancer)
08/2004 - 07/2002
3
Squamous Cell Carcinoma (Epidermoid Carcinoma)
07/2008 - 01/2007
3
Adenocarcinoma
02/2004 - 09/2003
2
Anoxia (Hypoxia)
05/2006 - 04/2006
2
Rectal Neoplasms (Rectal Cancer)
01/2006 - 10/2004
1
Adenomatous Polyposis Coli (Familial Adenomatous Polyposis)
03/2008
1
Aggressive Fibromatosis (Desmoid)
03/2008
1
Cholestasis
01/2008
1
Thrombocytopenia (Thrombopenia)
11/2007
1
Hyperbilirubinemia
11/2007
1
Gastrointestinal Neoplasms (Gastrointestinal Cancer)
08/2006
1
Hepatitis C
01/2006
1
Gallbladder Neoplasms (Gallbladder Cancer)
10/2004
1
Interstitial Lung Diseases (Interstitial Lung Disease)
08/2004
1
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
07/2004
1
Thyroid Neoplasms (Thyroid Cancer)
01/2004
Drug/Important Bio-Agent (IBA)
24
Fluorouracil (Carac)
FDA Link
Generic
01/2008 - 01/2002
20
Interferon-alpha (Interferon Alfa)
FDA Link
04/2008 - 01/2002
9
Doxorubicin (Adriamycin)
FDA Link
Generic
03/2008 - 10/2003
7
CDC48 protein
IBA
08/2004 - 02/2003
6
gemcitabine
FDA Link
01/2008 - 02/2003
6
Paclitaxel (Taxol)
FDA Link
Generic
01/2007 - 12/2002
6
Cisplatin (Platino)
FDA Link
Generic
10/2005 - 10/2003
5
titanium silicide (TS-1)
IBA
01/2006 - 05/2002
4
irinotecan (Camptosar)
FDA Link
Generic
02/2008 - 10/2004
4
oxaliplatin (Eloxatin)
FDA Link
01/2008 - 08/2005
4
hepatoma-derived growth factor
IBA
07/2007 - 01/2006
4
Interferons
IBA
05/2007 - 11/2002
4
Tubulin
IBA
02/2006 - 09/2002
4
Messenger RNA (mRNA)
IBA
01/2005 - 01/2002
3
Interferon-beta
IBA
12/2007 - 12/2003
3
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
10/2007 - 03/2006
3
docetaxel (Taxotere)
FDA Link
03/2007 - 08/2003
3
Xenon
IBA
08/2005 - 08/2003
2
connexin 26
IBA
03/2008 - 02/2008
2
doxifluridine
IBA
02/2008 - 03/2007
2
Interferon alpha-beta Receptor (Receptor, Interferon alpha beta)
IBA
01/2007 - 08/2006
2
Tegafur
IBA
08/2006 - 01/2006
2
Uracil
IBA
08/2006 - 01/2006
2
Cyclin D1
IBA
08/2006 - 11/2002
2
Angiopoietin-2
IBA
05/2006 - 04/2006
2
Cadherins (E-Cadherin)
IBA
02/2006 - 06/2002
2
Proteins (Proteins, Gene)
IBA
02/2005 - 11/2002
2
Estrogens (Estrogen)
FDA Link
11/2004 - 08/2004
2
Transferases
IBA
01/2004 - 01/2002
2
RNA-Directed DNA Polymerase (Reverse Transcriptase)
IBA
10/2002 - 07/2002
2
Calcium
IBA
09/2002 - 01/2002
1
Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)
FDA Link
07/2008
1
Dacarbazine (DIC)
FDA Link
Generic
03/2008
1
capecitabine (Xeloda)
FDA Link
02/2008
1
connective tissue-activating peptide (CTAP-III)
IBA
01/2008
1
Protein-Tyrosine Kinases (Tyrosine Kinase)
IBA
01/2008
1
Carbon Monoxide
IBA
11/2007
1
Angiopoietins
IBA
10/2007
1
Proto-Oncogene Protein c-ets-1
IBA
10/2007
1
Equilibrative Nucleoside Transporter 1
IBA
07/2007
1
Ribonucleotide Reductases (Ribonucleotide Reductase)
IBA
03/2007
1
Hydroxyeicosatetraenoic Acids (HETE)
IBA
02/2007
1
Cholesterol
IBA
01/2007
1
Matrix Metalloproteinase 16
IBA
01/2007
1
pullulan
IBA
01/2007
1
Ethanol (Ethyl Alcohol)
IBA
11/2006
1
Vitamin K 2 (Vitamin K2)
IBA
08/2006
1
Angiopoietin-1
IBA
03/2006
1
Biological Tumor Markers (Tumor Markers)
IBA
02/2006
1
Leucovorin (Folinic Acid)
FDA Link
Generic
01/2006
1
Dihydrouracil Dehydrogenase (NADP) (Dihydropyrimidine Dehydrogenase)
IBA
05/2005
1
Thymidine Phosphorylase
IBA
05/2005
1
alpha-Fetoproteins (AFP)
IBA
01/2005
1
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
12/2004
1
Platinum
IBA
12/2004
1
Metallothionein
IBA
12/2004
1
alpha 1-Antichymotrypsin (alpha 1 Antichymotrypsin)
IBA
11/2004
1
RNA (Ribonucleic Acid)
IBA
02/2004
1
Ligands
IBA
01/2004
1
Uridine Diphosphate (UDP)
IBA
01/2004
1
Acetylglucosamine
IBA
01/2004
1
Galactosamine
IBA
01/2004
Therapy/Procedure
24
Drug Therapy (Chemotherapy)
05/2008 - 09/2002
6
Combination Drug Therapy (Combination Chemotherapy)
04/2008 - 01/2004
5
Hepatectomy
04/2008 - 01/2002
4
Lymph Node Excision (Lymph Node Dissection)
01/2007 - 07/2002
3
Heterologous Transplantation (Xenotransplantation)
01/2008 - 10/2004
3
Liver Transplantation
01/2008 - 01/2006
2
Transplants (Transplant)
11/2007 - 11/2007
2
Splenectomy
01/2007 - 02/2005
2
Gastrectomy
02/2005 - 10/2003
1
Stents
01/2008
1
Neoadjuvant Therapy
09/2007
1
Combined Modality Therapy
09/2004